These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 37738097)
1. Opening the door to physiological impacts underlying opioid-induced respiratory depression and therapeutic strategies: focus on fentanyl. Baldo BA J Physiol; 2023 Oct; 601(20):4473-4474. PubMed ID: 37738097 [No Abstract] [Full Text] [Related]
2. A comparative examination of morphine and fentanyl: unravelling the differential impacts on breathing and airway stability. Burgraff NJ; Baertsch NA; Ramirez JM J Physiol; 2023 Oct; 601(20):4625-4642. PubMed ID: 37778015 [TBL] [Abstract][Full Text] [Related]
3. Noradrenergic Mechanisms in Fentanyl-Mediated Rapid Death Explain Failure of Naloxone in the Opioid Crisis. Torralva R; Janowsky A J Pharmacol Exp Ther; 2019 Nov; 371(2):453-475. PubMed ID: 31492824 [TBL] [Abstract][Full Text] [Related]
5. Countering Opioid-induced Respiratory Depression in Male Rats with Nicotinic Acetylcholine Receptor Partial Agonists Varenicline and ABT 594. Ren J; Ding X; Greer JJ Anesthesiology; 2020 May; 132(5):1197-1211. PubMed ID: 32294065 [TBL] [Abstract][Full Text] [Related]
6. Fentanyl causes naloxone-resistant vocal cord closure: A platform for testing opioid overdose treatments. Miner NB; Schutzer WE; Zarnegarnia Y; Janowsky A; Torralva R Drug Alcohol Depend; 2021 Oct; 227():108974. PubMed ID: 34492557 [TBL] [Abstract][Full Text] [Related]
7. Fentanyl-Induced Respiratory Depression and Locomotor Hyperactivity Are Mediated by μ-Opioid Receptors Expressed in Somatostatin-Negative Neurons. Furdui A; da Silveira Scarpellini C; Montandon G eNeuro; 2023 Jun; 10(6):. PubMed ID: 37364996 [TBL] [Abstract][Full Text] [Related]
8. In vivo profiling of seven common opioids for antinociception, constipation and respiratory depression: no two opioids have the same profile. Kuo A; Wyse BD; Meutermans W; Smith MT Br J Pharmacol; 2015 Jan; 172(2):532-48. PubMed ID: 24641546 [TBL] [Abstract][Full Text] [Related]
9. Opioid-induced respiratory effects: new data on buprenorphine. Dahan A Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215 [TBL] [Abstract][Full Text] [Related]
11. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
13. Opioid receptor mechanisms at the hypoglossal motor pool and effects on tongue muscle activity in vivo. Hajiha M; DuBord MA; Liu H; Horner RL J Physiol; 2009 Jun; 587(Pt 11):2677-92. PubMed ID: 19403616 [TBL] [Abstract][Full Text] [Related]
14. Effect of sustained high buprenorphine plasma concentrations on fentanyl-induced respiratory depression: A placebo-controlled crossover study in healthy volunteers and opioid-tolerant patients. Moss LM; Algera MH; Dobbins R; Gray F; Strafford S; Heath A; van Velzen M; Heuberger JAAC; Niesters M; Olofsen E; Laffont CM; Dahan A; Groeneveld GJ PLoS One; 2022; 17(1):e0256752. PubMed ID: 35085249 [TBL] [Abstract][Full Text] [Related]
15. Non-analgesic effects of opioids: opioid-induced respiratory depression. Boom M; Niesters M; Sarton E; Aarts L; Smith TW; Dahan A Curr Pharm Des; 2012; 18(37):5994-6004. PubMed ID: 22747535 [TBL] [Abstract][Full Text] [Related]
16. Characteristics and comparative severity of respiratory response to toxic doses of fentanyl, methadone, morphine, and buprenorphine in rats. Chevillard L; Mégarbane B; Risède P; Baud FJ Toxicol Lett; 2009 Dec; 191(2-3):327-40. PubMed ID: 19819313 [TBL] [Abstract][Full Text] [Related]
17. Morphine-induced muscle rigidity in a term neonate. van der Lee R; Ceelie I; de Wildt SN Ann Pharmacother; 2009 Oct; 43(10):1724-6. PubMed ID: 19755623 [TBL] [Abstract][Full Text] [Related]
18. Naloxone reversal of opioid-induced respiratory depression with special emphasis on the partial agonist/antagonist buprenorphine. Sarton E; Teppema L; Dahan A Adv Exp Med Biol; 2008; 605():486-91. PubMed ID: 18085322 [TBL] [Abstract][Full Text] [Related]
19. Heroin- and Fentanyl-Induced Respiratory Depression in a Rat Plethysmography Model: Potency, Tolerance, and Sex Differences. Marchette RCN; Carlson ER; Frye EV; Hastings LE; Vendruscolo JCM; Mejias-Torres G; Lewis SJ; Hampson A; Volkow ND; Vendruscolo LF; Koob GF J Pharmacol Exp Ther; 2023 May; 385(2):117-134. PubMed ID: 36828628 [TBL] [Abstract][Full Text] [Related]